All Four Leading Independent Proxy Advisory Firms Recommend Pharmion
stockholders vote FOR merger with Celgene
Special Meeting of Shareholders Scheduled For March 6, 2008 Pharmion Corp. Urges All Shareholders to Vote FOR the Proposed Merger
BOULDER, Colo., Feb. 26 /PRNewswire-FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM) today announced that Institutional Shareholder Services (ISS) has recommended that Pharmion stockholders vote FOR the merger agreement with Celgene Corporation (Nasdaq: CELG) at the Special Stockholders Meeting scheduled for March 6, 2008. With this recommendation, all four of the leading proxy advisory firms, ISS, Glass Lewis & Co., PROXY Governance, Inc. and Egan-Jones Proxy Services, have now recommended that Pharmion stockholders support the merger with Celgene.
"We are pleased that ISS, as well as the other leading independent proxy advisory firms -- Glass Lewis & Co., PROXY Governance and Egan-Jones Proxy Services -- have all recognized the strategic and economic logic of our merger with Celgene," said Patrick Mahaffy, Pharmion's president and chief executive officer. "ISS' conclusions confirm our conviction that the merger offers the best value to Pharmion stockholders."
ISS is a leading independent U.S. proxy advisory firm and its voting analyses and recommendations are relied upon by hundreds of major institutional investment funds, mutual funds and fiduciaries throughout the country.
The Board of Directors of Pharmion unanimousl
|SOURCE Pharmion Corporation|
Copyright©2008 PR Newswire.
All rights reserved